Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial-Reference-Cited by-同舟云学术

Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial

Published:2011-11-15 Issue:2 Volume:35 Page:190-195
ISSN:0105-6263
Container-title:International Journal of Andrology
language:en
Short-container-title:

Author:

Palmieri A.,Imbimbo C.,Creta M.,Verze P.,Fusco F.,Mirone V.

Publisher

Wiley

Subject

Urology,Reproductive Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2605.2011.01226.x/fullpdf

Reference25 articles.

1. Peyronie’s disease: advances in basic science and pathophysiology;Bivalacqua;Curr Urol Rep,2000

2. An alternative non-invasive treatment for Peyronie’s disease;Claro;Int Braz J Urol,2004

3. Peyronie’s Disease: Can We Prevent Disease Progression?;Dohle;Eur Urol,2006

4. Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option;Donatucci;Curr Med Res Opin,2008

5. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie’s disease;Ferrini;BJU Int,2006

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vacuum Erection Device Plus Once-Daily Tadalafil Improve Clinical Outcomes after Extracorporeal Shock Wave Therapy in Men Affected by Erectile Dysfunction Associated with Peyronie’s Disease;Life;2024-09-13

2. Acute Phase Peyronie’s Disease: Where Do We Stand?;Cureus;2024-08-17

3. Prise en charge de la maladie de Lapeyronie au stade précoce, une revue narrative de la littérature;Progrès en Urologie - FMC;2024-06

4. Male sexual dysfunction;Penn Clinical Manual of Urology;2024

5. A new alternative approach to management of acute phase Peyronie's disease: low intensity extracorporeal shockwave therapy and platelet-rich plasma;Minerva Urology and Nephrology;2023-12